Provider-led, every single time
Nothing is prescribed without a licensed provider reviewing your intake. The provider — not an algorithm and not a salesperson — decides whether peptide therapy is appropriate, which peptide fits, and whether to decline. Declining is a real outcome: if the risk-benefit picture doesn't make sense for you, the right answer is no.
This matters most for peptides because the gray market around them is large and largely unregulated. A supervised medical relationship is the difference between a therapy and a gamble.
Intake screening
Our intake asks about your health history, current medications, and goals specifically so a provider can spot contraindications. Some conditions and drug combinations make particular peptides a poor idea — for instance, a personal or family history of certain cancers is relevant to peptides that act on the growth-hormone axis.
Being thorough and honest on the intake is the single biggest thing you can do to make the review meaningful. Leaving things out doesn't make therapy safer; it just makes the screen blind.
Lab-guided care
For several peptides, your provider may order baseline labs before prescribing and follow-up labs afterward. Labs do two jobs: they confirm a peptide is reasonable to start, and they create a before/after picture so anything concerning can be caught early. Which panel is relevant depends on the peptide, and your provider chooses it.
Not every peptide requires labs, and we note on each profile whether baseline labs are typically expected so there are no surprises.
Sourcing and what we don't do
Medications come from licensed pharmacies — either an FDA-approved product or a preparation from a licensed compounding pharmacy. We don't sell raw materials, bulk powder, or anything labeled for non-medical use. We don't publish self-administration walkthroughs, dosing math, or 'stack' builders.
Peptide therapy here is a supervised medical service, prescribed and overseen by a licensed provider. If you see a site offering vials with no prescription and no provider, that's a different and riskier thing entirely — and one we'd encourage you to steer clear of.